DV
Dividend Vision

PBH Stock — Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare Inc. (PBH)

Updated October 16, 2026.

PBH is a Stock. Total return is 187.3% over the past 21.7 years, 659.7 points behind SPY at 847.0%.

Prestige Consumer Healthcare Inc. develops, manufactures, and distributes over-the-counter health and personal care products across North America, Australia, and international markets, with brands including BC, Goody's, Chloraseptic, Clear Eyes, Dramamine, Fleet, Monistat, and Summer's Eve. The company does not currently distribute to shareholders. This business appeals to value and income investors seeking exposure to established consumer healthcare brands with steady demand.

PBH dividend yield and income

Price as of 2026-10-16.

The ex-dividend date is 09/27/2018. The payment date is 10/15/2018.

2 recorded distributions
Ex-dateAmountChange from previous payment
2018-09-27$0.47552.0%
Unclassified cash
2013-12-27$0.3125—
2013 total$0.3125—
2018 total$0.47552.0%

PBH performance versus SPY

Price and return data through 2026-10-16.

Total return is 187.3% over the past 21.7 years, 659.7 points behind SPY at 847.0%. Over the past year its total return — price change plus distributions reinvested — is -19.2%. Its deepest 1-year drawdown was 36.2%.

WindowTotal returnCAGR
1M6.5%—
3M-1.3%—
6M-12.5%—
YTD-19.1%—
1Y-19.2%—
2Y CAGR—-16.70%
3Y CAGR—-6.10%
5Y CAGR—-3.10%
10Y CAGR—0.70%
Since inception (21.7 years)187.3%5.00%

PBH key facts

Asset type
Stock
Asset class
Equity
Inception date
02/10/2005
Distribution frequency
None
Last close
$49.92 (as of 2026-10-16)
Market cap
$2,364,936,138
Average volume
580659.0
Ex-dividend date
09/27/2018
Payment date
10/15/2018
Beta
0.342
Payout ratio
0.0%
P/E ratio
13.98
Forward P/E
10.5485
EPS
$3.57

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

PBH risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 36.2%.

Who may consider PBH — and who may not

It is a weaker fit for investors who need monthly cash flow (PBH does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on PBH

Tagged: Healthcare, Pharmaceutical.

Frequently asked questions

Does PBH pay monthly?

No. PBH does not currently distribute.

When does PBH pay a dividend?

PBH does not currently distribute. The ex-dividend date is 09/27/2018. The payment date is 10/15/2018.

How has PBH performed?

Total return is 187.3% over the past 21.7 years, 659.7 points behind SPY at 847.0%. Over the past year its total return — price change plus distributions reinvested — is -19.2%. Its deepest 1-year drawdown was 36.2%.

DividendVision analysis is generated from public SEC filing data and may not capture every change. Review the original filing for complete information.